Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC vs. THC/CBD vs. Placebo for Insomnia in Cancer Patients
NCT07565974Phase 2Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Oct 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol, cannabidiol in Insomnia, sponsored by Mayo Clinic. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07565974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07565974.